Recursion Pharmaceuticals' Grant - IV Round

Recursion Pharmaceuticals raised a round of funding on November 09, 2018. Investors include National Institute on Aging.

Recursion Pharmaceuticals leverages biological science, computation and artificial intelligence to provide a platform that discovers treatments for rare genetic disease and other conditions including …

Articles about Recursion Pharmaceuticals' Grant - IV Round: